Insulin and insulin-sensitizer combinations significantly improve hyperglycemia; however, there is an increased incidence of heart failure reported with this combination, prompting close monitoring of patients for signs and symptoms of heart failure [27]. The gene discussed is INS; the disease is heart failure.